Baxter lost his patent suit on Becton Dickinson’s drug delivery technology

A device created by combining two parts Becton Dickinson and Company The PhaSeal system, which safely transfers drugs between syringes and vials, does not breach the two. Baxter International Inc. patent, an Illinois federal judge ruled on Monday.

Judge Joan H. LefkowIn its opinion, the U.S. District Court for the Northern District of Illinois granted BD’s motion for summary judgment, stating that the combination of the “defensive” and “injection” elements to create the device does not infringe either. Patent.

It rejected Baxter’s theory of joint direct infringement with respect to one patent…